Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway - Chang, T-C; Chiou, W-C; Lai, W-H; Huang, H-C; Huang, Y-L; Liu, H-K (Pharmacol Res, 2021)